--- title: "NYC AI Copilot Startups for Professionals 2026: Meetings, Legal, Finance, Clinical" description: "A 2026 workflow map of AI copilots for professionals bought and built around NYC — meetings (Granola), legal (Harvey), finance (AlphaSense, Hebbia), clinical (Avo) — with funding signals and clear lines vs agents and document AI." date: 2026-07-25T00:00:00.000Z tags: ["vc-explainers", "nyc-startups", "ai", "ai-copilots", "market-analysis"] source: https://venturecapitaltracker.com/nyc-ai-copilot-startups-professionals-2026 --- # NYC AI Copilot Startups for Professionals 2026: Meetings, Legal, Finance, Clinical > A 2026 workflow map of AI copilots for professionals bought and built around NYC — meetings (Granola), legal (Harvey), finance (AlphaSense, Hebbia), clinical (Avo) — with funding signals and clear lines vs agents and document AI. **Short answer (as of July 2026):** NYC’s professional AI story is **workflow copilots sold into law, finance, clinical, and meeting-heavy operators** — not foundation models. The companies to know are **Granola** ($125M Series C, Mar 2026, $1.5B; London HQ), **Harvey** (legal; SF HQ, deep NYC AmLaw demand), **AlphaSense** ($350M at $7.5B, Jun 2026; NYC), **Hebbia** ($130M Series B; NYC document reasoning), **Avo** ($10M Series A, 2026; NYC clinical), and **Zenskar** ($15M Series A; NYC agentic billing). Treat HQ honestly: many “NYC AI copilots” are **bought in NYC** even when built elsewhere. ### Copilots vs agents vs document AI | Category | Job | Human role | NYC example | |---|---|---|---| | **Copilot** | Draft, suggest, summarize inside a live professional workflow | Always in the loop; approves output | Avo Chart Assist; Harvey drafting assist; Granola notes | | **Agent** | Multi-step execute (reconcile, bill, file, message systems) | Supervises outcomes / exceptions | [Zenskar](/startup/zenskar) billing agents; many names on the [agents map](/nyc-ai-agents-startup-scene-2026-map) | | **Document AI** | Ingest, extract, compare large document sets | Sets the query / reviews table of answers | [Hebbia](/startup/hebbia) Matrix; diligence/e-discovery tools | Products migrate: Granola started as a meeting notepad and is shipping APIs/MCP so other agents can use meeting context — still a **professional copilot** at the UI, with **agent infrastructure** underneath. Hebbia is often sold as knowledge-worker AI but is primarily **document reasoning** (a natural bridge to a document-AI map). ### Workflow map (Startup · Professional workflow · Vertical · Funding signal · Investors) | Startup | Professional workflow | Vertical | Funding signal | Investors / notes | |---|---|---|---|---| | **[Granola](/startup/granola)** | Meeting capture → structured notes → team context / APIs | Meetings / ops | **$125M Series C** (Mar 2026) at **$1.5B**; ~$192M total | Index Ventures (lead), Kleiner Perkins; Lightspeed, Spark, NFDG. **London HQ**; strong US/NYC professional usage. Detail: [/2026-granola-125m-enterprise-ai](/2026-granola-125m-enterprise-ai) | | **[Harvey](/startup/harvey)** | Legal research, drafting, doc analysis for AmLaw workflows | Legal | **$300M Series D** (Feb 2025) at **~$3B** | [Sequoia](/fund/sequoia) (lead D), a16z, Coatue, Kleiner Perkins, OpenAI Startup Fund, GV. **SF HQ**; **NYC is a primary buyer market**. | | **[AlphaSense](/startup/alphasense)** | Market intel search, transcript/filing Q&A for analysts | Finance / research | **$350M** (Jun 2026) at **$7.5B**; $1B+ raised | Vitruvian (lead), Accenture Ventures, J.P. Morgan AM, D.E. Shaw Ventures. **NYC HQ**. | | **[Hebbia](/startup/hebbia)** | Multi-document diligence / tabular research (Matrix) | Finance / legal (document AI) | **$130M Series B** (2024) at ~$700M | a16z (lead), Index Ventures, GV, Peter Thiel. **NYC HQ** (Spring St.). | | **[Avo](/startup/avo)** | EHR copilots (chart assist, orders, evidence at point of care) | Clinical | **$10M Series A** (Mar 2026) | Noro-Moseley (lead), AlleyCorp, Las Olas, MedMountain, Epsilon Health, Scrub. **NYC HQ**. | | **[Zenskar](/startup/zenskar)** | Order-to-cash / complex B2B billing automation | Finance / RevOps | **$15M Series A** (Apr 2026) | Susquehanna (lead), Bessemer, Shine, Rho. **NYC HQ**. **Agentic** more than classic copilot — included as the finance boundary case. | **Scope note:** This is a **buyer-and-builder map for professionals in NYC**, not a pure HQ census. We exclude horizontal ChatGPT wrappers and foundation labs. ### Meetings: Granola and the notepad → context stack Granola’s bet is that professionals will not tolerate meeting bots, but will pay for **local transcription + structured notes + enterprise context**. The Mar 2026 round (Index / Kleiner) priced that shift at **$1.5B**. Competitors (Otter, Fireflies, Zoom AI Companion, Microsoft Copilot) commoditize raw notes; Granola’s differentiation is **privacy posture + APIs/MCP** so meeting memory feeds other tools. For founders selling into NYC operators, the lesson is measurable: time-to-usable notes and governance, not “AI meeting magic.” Full deal write-up: [Granola’s $125M](/2026-granola-125m-enterprise-ai). ### Legal: Harvey (SF) + NYC AmLaw demand Harvey is the category flagship for **AI copilots for professionals** in law — research, drafting, and document analysis with high willingness to pay. **HQ is San Francisco**; the reason it belongs on an NYC map is buyer density: 50+ AmLaw 100 offices, corporate GCs, SDNY/EDNY litigation, and NYDFS/SEC adjacency. NYC-native legal AI names (Spellbook, Eve, Garvanza, Avanta, and capital-markets specialists like Nolan) are earlier or thinner on disclosed rounds — treat them as watchlist, not funded peers of Harvey. Deeper legal context: [NYC legal tech 2026](/nyc-legal-tech-harvey-everlaw-casetext-ai-law) and [Harvey / a16z](/2026-a16z-harvey-why-it-matters). ### Finance: AlphaSense copilots vs Hebbia document AI - **AlphaSense (NYC)** is the scaled **market-intelligence copilot**: sourced answers over filings, transcripts, and research for analysts and strategy teams. The June 2026 **$350M / $7.5B** mark is a signal that enterprises pay for **citations + workflow**, not chat novelty. - **Hebbia (NYC)** owns **multi-document reasoning** for banking and professional services — closer to document AI than a chat sidebar. Include it when scouting “AI for knowledge workers,” but do not blur it into meeting copilots. Zenskar sits on the **agent** side of finance (billing execution). Pair it with the [agents map](/nyc-ai-agents-startup-scene-2026-map) when diligence requires autonomous revenue workflows. ### Clinical: Avo’s EHR-native copilots Avo (NYC) raised **$10M Series A** (Noro-Moseley lead; AlleyCorp and health-focused angels/VCs) to put copilots **inside Epic / athena / MEDITECH workflows** — chart assist, documentation, evidence routing — with partnerships aimed at reducing hallucination risk (e.g. DynaMed / EBSCO). That is the clinical definition of an AI copilot for professionals: point-of-care, governed, EHR-embedded. Deal notes: [Avo $10M Series A](/2026-avo-10m-series-a-clinical-ai). ### Who funds this category in NYC Specialists that repeatedly show up around applied enterprise AI (copilots and agents): - [Work-Bench](/fund/work-bench) — enterprise / infra angle - [Primary Venture Partners](/fund/primary-venture-partners) — NYC-focused early - [Insight Partners](/fund/insight-partners) — growth software - [Thrive Capital](/fund/thrive-capital), [Union Square Ventures](/fund/union-square-ventures), [Lerer Hippeau](/fund/lerer-hippeau) — adjacent NYC AI/software Global names (Sequoia, a16z, Index, Kleiner, Bessemer) still lead many of the largest rounds; link only where we have fund pages. ### Founder / investor take 1. **Pitch the workflow, not the model** — lawyers, clinicians, and analysts buy time saved inside systems of record. 2. **Label your product honestly** — copilot vs agent vs document AI changes buyer, security review, and competitive set. 3. **NYC advantage is distribution** — AmLaw, banks, PE, and health systems are walking-distance buyers; HQ can be elsewhere if GTM is here. 4. **Cross-read** — autonomous stack: [NYC AI agents 2026 map](/nyc-ai-agents-startup-scene-2026-map); meeting infrastructure: [Granola $125M](/2026-granola-125m-enterprise-ai). ### Known gaps - Several promising NYC legal AI names lack clean, recent round disclosures suitable for ranking. - “AI copilots for professionals” queries sometimes intend Microsoft Copilot / Google Duet — those are **incumbent suites**, not startups; we do not treat them as peers here. - Document-AI cluster depth (beyond Hebbia/Granola adjacency) belongs in a dedicated document startups piece. ### Sources 1. Granola Series C (TechCrunch, Mar 25, 2026): https://techcrunch.com/2026/03/25/granola-raises-125m-hits-1-5b-valuation-as-it-expands-from-meeting-notetaker-to-enterprise-ai-app/ 2. Granola Series C (company): https://www.granola.ai/blog/series-c 3. Harvey Series D (company blog): https://www.harvey.ai/blog/harvey-raises-series-d 4. AlphaSense $350M (Crunchbase News, Jun 2026): https://news.crunchbase.com/venture/biggest-funding-rounds-june-5-2026/ 5. Hebbia Series B (TechCrunch, Jul 2024): https://techcrunch.com/2024/07/09/ai-startup-hebbia-rased-130m-at-a-700m-valuation-on-13-million-of-profitable-revenue/ 6. Avo $10M Series A (company, Mar 31, 2026): https://www.avomd.com/resources/avo-raises-10-million-series-a-to-be-the-clinical-ai-platform-powered-by-trusted-knowledge 7. Zenskar $15M Series A (BusinessWire, Apr 2026): https://www.businesswire.com/news/home/20260416872552/en/Zenskar-Raises-%2415-Million-Series-A-to-Expand-Agentic-Capabilities-for-B2B-Revenue-Automation 8. Related VCT maps: [/nyc-ai-agents-startup-scene-2026-map](/nyc-ai-agents-startup-scene-2026-map), [/2026-granola-125m-enterprise-ai](/2026-granola-125m-enterprise-ai)